In glioblastoma (GBM) stem cells, palmitoylation Glycogen synthase kinase 3β (GSK3β) at Cys14 mediated by ZDHHC4 can activate STAT3 signaling to improve the stemness of temozolomide (TMZ)-resistant GBM.110. Here, STAT3 is linked to glioblastoma.